Temoporfin
Foscan (temoporfin) is a small molecule pharmaceutical. Temoporfin was first approved as Foscan on 2001-10-24. It has been approved in Europe to treat head and neck neoplasms and squamous cell carcinoma.
| Trade Name | Foscan |
|---|---|
| Common Name | Temoporfin |
| Indication | head and neck neoplasms, squamous cell carcinoma |
| Drug Class | Benzoporphyrin derivatives |
